ADCT
Price
$1.18
Change
-$0.05 (-4.07%)
Updated
Apr 4 closing price
Capitalization
116.92M
37 days until earnings call
CHRS
Price
$0.78
Change
-$0.04 (-4.88%)
Updated
Apr 4 closing price
Capitalization
94.72M
33 days until earnings call
Ad is loading...

ADCT vs CHRS

Header iconADCT vs CHRS Comparison
Open Charts ADCT vs CHRSBanner chart's image
ADC Therapeutics SA
Price$1.18
Change-$0.05 (-4.07%)
Volume$691.57K
Capitalization116.92M
Coherus BioSciences
Price$0.78
Change-$0.04 (-4.88%)
Volume$1.88M
Capitalization94.72M
ADCT vs CHRS Comparison Chart
Loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADCT vs. CHRS commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Buy and CHRS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (ADCT: $1.23 vs. CHRS: $0.82)
Brand notoriety: ADCT and CHRS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 115% vs. CHRS: 125%
Market capitalization -- ADCT: $116.92M vs. CHRS: $94.72M
ADCT [@Biotechnology] is valued at $116.92M. CHRS’s [@Biotechnology] market capitalization is $94.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 0 FA rating(s) are green whileCHRS’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 0 green, 5 red.
  • CHRS’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than CHRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 5 TA indicator(s) are bullish while CHRS’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 5 bullish, 5 bearish.
  • CHRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ADCT and CHRS are a good buy in the short-term.

Price Growth

ADCT (@Biotechnology) experienced а -19.08% price change this week, while CHRS (@Biotechnology) price change was -4.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

ADCT is expected to report earnings on May 12, 2025.

CHRS is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADCT($117M) has a higher market cap than CHRS($94.7M). ADCT YTD gains are higher at: -38.191 vs. CHRS (-40.819). CHRS has higher annual earnings (EBITDA): 37.3M vs. ADCT (-110.43M). ADCT has more cash in the bank: 274M vs. CHRS (97.7M). ADCT has less debt than CHRS: ADCT (125M) vs CHRS (270M). CHRS has higher revenues than ADCT: CHRS (304M) vs ADCT (70.7M).
ADCTCHRSADCT / CHRS
Capitalization117M94.7M124%
EBITDA-110.43M37.3M-296%
Gain YTD-38.191-40.81994%
P/E RatioN/A3.27-
Revenue70.7M304M23%
Total Cash274M97.7M280%
Total Debt125M270M46%
FUNDAMENTALS RATINGS
CHRS: Fundamental Ratings
CHRS
OUTLOOK RATING
1..100
70
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTCHRS
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 29 days ago
79%
Bullish Trend 15 days ago
73%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ADCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENLAY8.530.35
+4.28%
ENEL Societa per Azioni
WDOFF11.750.26
+2.26%
Wesdome Gold Mines Ltd.
BKKLY22.73-0.66
-2.82%
Bangkok Bank Public Co Ltd.
EPIAF19.37-0.58
-2.91%
Epiroc Aktiebolag
CNTMF0.05-0.01
-10.00%
FLUENT CORP

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CLRB. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
-7.52%
CLRB - ADCT
47%
Loosely correlated
+0.41%
ANAB - ADCT
41%
Loosely correlated
+1.69%
PRME - ADCT
39%
Loosely correlated
-10.06%
AURA - ADCT
38%
Loosely correlated
-3.87%
VTYX - ADCT
37%
Loosely correlated
-5.66%
More

CHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with ADCT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then ADCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHRS
1D Price
Change %
CHRS100%
-10.28%
ADCT - CHRS
39%
Loosely correlated
-7.52%
ARRY - CHRS
39%
Loosely correlated
-10.32%
AXON - CHRS
38%
Loosely correlated
-3.35%
AMRN - CHRS
35%
Loosely correlated
-2.18%
SRRK - CHRS
34%
Loosely correlated
-5.65%
More